Muscle Tissue Engineering is an interdisciplinary field that combines principles of biology, materials science, and engineering to create functional and viable muscle tissue for therapeutic applications. The goal of muscle tissue engineering is to repair or replace damaged muscle tissue caused by injuries, congenital defects, or degenerative diseases. This approach offers potential solutions for muscle regeneration beyond traditional treatments. Researchers utilize biomaterial scaffolds, which mimic the extracellular matrix, to provide structural support for cell attachment, proliferation, and differentiation. Cells, often myoblasts or stem cells with myogenic potential, are seeded onto these scaffolds, creating a conducive environment for tissue formation. Bioreactors may be employed to enhance nutrient and oxygen delivery, simulating physiological conditions for optimal tissue development. Electrical and mechanical stimulation is frequently applied to promote maturation and functional integration of engineered muscle tissue. This ensures that the resulting muscle mimics the contractile properties of native tissue, making it suitable for transplantation or integration into the host. Muscle tissue engineering holds promise for treating conditions such as volumetric muscle loss, where large portions of muscle tissue are lost, and for creating in vitro models for drug testing and disease study. Challenges include achieving vascularization within engineered muscle and addressing the complexity of muscle tissue's hierarchical organization. As technology advances, muscle tissue engineering continues to progress, offering hope for innovative therapeutic strategies and the restoration of muscle function in various clinical scenarios. Ongoing research aims to refine techniques, improve biomaterials, and enhance the functional capabilities of engineered muscle tissue for broader clinical applications.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Progenitor cell mobilization and induced neutrophilia promote neovascularization and fibrinolysis in chronically ischemic tissue
Darwin Eton, Vasogenesis Inc, United States
Title : AI-integrated high-throughput tissue-chip for brain aging
Kunal Mitra, Florida Tech, United States
Title : Assembly and stability of on-chip microvasculature
Kara E McCloskey, University of California, Merced, United States